Effect of adriamycin treatment on the lifetime of pyrene butyric acid in single living cells

Free Radical Research

Volumn 39, Issue 6, 2005, Pages 581-588

  Rharass, Tareck ^a   Ribou, Anne Cecile ^a   Vigo, Jean ^a   Salmon, Jean Marie ^a  

^a UNIVERSITÉ DE PERPIGNAN   (France)

Author keywords

Adriamycin; Lifetime; Living cells; Oxygen; Pyrene butyric acid; Reactive oxygen species

Indexed keywords

BUTYRIC ACID; DOXORUBICIN; NITROGEN; OXYGEN; PYRENE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

CELL FUNCTION; CONTROLLED STUDY; DRUG MECHANISM; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HYPOTHESIS; LIFESPAN; OXYGEN CONCENTRATION; REVIEW;

CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; FLUORESCENCE; HALF-LIFE; HUMANS; NAD; OXYGEN; PYRENES; SPECTROMETRY, FLUORESCENCE;

EID: 20544434967     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760500084540     Document Type: Review

References (26)

1. Vaughan WM, Weber G. Oxygen quenching of pyrenebutyric acid fluorescence in water. A dynamic probe of the microenvironment. Biochemistry 1970;3:464-473.
2. Fischkoff S, Vanderkooi JM. Oxygen diffusion in biological and artificial membranes determined by the fluorochrome pyrene. J Gen Physiol 1975;65:663-676.
3. Dumas D, Muller S, Gouin F, Baros F, Viriot M-L, Stoltz J. Membrane fluidity and oxygen diffusion in cholesterol-enriched erythrocyte membrane. Arch Biochem Biophys 1997;341:34-39.
4. Fujiwara Y, Okura I, Miyashita T, Amao Y. Optical oxygen sensor based on fluorescence change of pyrene-1-butyric acid chemisorption film on an anodic oxidation aluminium plate. Anal Chim Acta 2002;471:25-32.
5. Lissi EA, Caceres T. Oxygen diffusion-concentration in erythrocyte plasma membranes studied by the fluorescence quenching of anionic and cationic pyrene derivatives. j Bioenerg Biomembr 1989;21:375-385.
6. Kohen E, Salmon JM, Kohen C, Bengtsson G. Microspectro-fluoremetric evaluation of the oxygen probe 1-pyrene butyric acid in single living cells. Exp Cell Res 1974;89:105-110.
7. Huglin D, Seiffert W, Zimmermann HW. Time-resolved microfluorometric study of the binding sites of lipophilic cationic pyrene probes in mitochondria of living HeLa cells. J Photochem Photobiol B: Biol 1995;31:145-158.
8. Ribou AC, Vigo J, Salmon JM. Synthesis and characterization of (1-pyrene butyl)-2-rhodamine ester: A new probe for oxygen measurement in mitochondria of living cells. J Photochem Photobiol A: Chem 2002;151:49-55.
9. Ribou A-C, Vigo J, Viallet PM, Salmon J-M. Oxygen measurement in living cells: Comparison between a new vital fluorescent Pyrene probe labeling mitochondria and Pyrene Butyric Acid. Proc SPIE Int Soc Opt Eng 2002;4622:1-10.
10. Ribou A-C, Vigo J, Salmon J-M. Lifetime of fluorescent pyrene butyric acid probe in single living cells for measurement of oxygen fluctuation. Photochem Photobiol 2004; 80:274-280.
11. Angelescu D, Vasilescu M. Quenching of pyrene derivatives fluorescence by nitroxide radicals in sodium dodecyl sulfate micellar solutions. J Colloid Interface Sci 2001;244:139-144.
12. Cramb DT, Beck SC. Fluorescence quenching mechanisms in micelles: The effect of high quencher concentration. J Photochem Photobiol A: Chem 2000;134:87-95.
13. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 2nd ed. New York: Oxford University Press; 1989.
14. Erecinska M, Silver IA. Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol 2001;128:263-276.
15. Frishman WH, Sung HM, Yee HCM. Cardiovascular toxicity with cancer chemotherapy. Curr Probl Cardiol 1996;21:225-288.
16. Ravid A, Rocker D, Machlenkin A, Rotem C, Hochman A, Kessler-Icekson G, Liberman UA, Koren R. 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res 1999;59:862-867.
17. Minotti G, Licata S, Saponiero A, Menna P, Calafiore AM, Di Giammarco G, Liberi G, Animati F, Cipollone A, Manzini, et al. Anthracycline metabolism and toxicity in human myocardium: Comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite. Chem Res Toxicol 2000;13:1336-1341.
18. Olson RD, Mushlin PS. Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses. FASEB J 1990;4:3076-3086.
19. Doroshow JH. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase. Cancer Res 1983;43: 4543-4551.
20. Myers C. The role of iron in doxorubicin-induced cardiomyopathy. Semin Oncol 1998;25:10-14.
21. Valeur B. Analysis of time-dependent fluorescence experiments by the method of modulating functions with special attention to pulse fluorometry. Chem Phys 1978;30:85-93.
22. O'Connor DV, Ware WR, Andre JC. Deconvolution of fluorescence decay curves. A critical comparison of techniques. J Phys Chem 1979;83:1333-1343.
23. Vigo J, Lahmy S, Salmon JM, Viallet P. Fluorescence decay curves under pulsed excitation: distinction between free and bound NAD(P)H on isolated living cells. CR Acad Sci III-Vie 1984;299:489-494.
24. Savatier J, Vigo J, Salmon J-M. Monitoring cell cycle distributions in living cells by videomicrofluorometry and discriminant factorial analysis. Cytometry 2003;56A:8-14.
25. Savatier J, Gbankoto A, Vigo J, Salmon J-M. Videomicrofluorometry on living cells and discriminant factorial analysis to study cell cycle distributions. J Biol Regul Homeost Agents 2004;18:206-211.
26. Lothstein L, Israel M, Sweatman TW. Anthracycline drug targeting: Cytoplasmic versus nuclear-a fork in the road. Drug Resist Update 2001;4:169-177.